Effects of parenteral nutrition on the exocrine pancreas in response to cholecystokinin

Journal of Parenteral and Enteral Nutrition

Volumn 32, Issue 1, 2008, Pages 57-62

  Fan, Bo Guang ^a  

^a TAIZHOU HOSPITAL OF ZHEJIANG PROVINCE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLECYSTOKININ; GASTROINTESTINAL HORMONE;

ENTERIC FEEDING; GASTROINTESTINAL ABSORPTION; GASTROINTESTINAL TRACT; GASTROINTESTINAL TRACT FUNCTION; NONHUMAN; PANCREAS; PRIORITY JOURNAL; REVIEW;

ANIMALS; CHOLECYSTOKININ; HUMANS; PANCREAS, EXOCRINE; PARENTERAL NUTRITION;

EID: 38349053331     PISSN: 01486071     EISSN: None     Source Type: Journal    
DOI: 10.1177/014860710803200157     Document Type: Review

References (83)

1. Dudrick SJ, Wilmore DW, Vars HM. Long-term total parenteral nutrition with growth, development, and positive nitrogen balance. Surgery. 1968;64:134-142.
2. Meguid MM, Muscaritoli M. Current use of total parenteral nutrition. Am Fam Physician. 1993;47:383-394.
3. Pisters PW, Ranson JH. Nutritional support for acute pancreatitis. Surg Gyn Obstet. 1992;175:275-284.
4. Jognson LR, Larry MS, Stanley JD. Effect of long-term parenteral feeding on pancreatic secretion and serum secretin. Am J Physiol. 1977;233:E524-E529.
5. Ekelund M, Ekelund M, Qader SS, Hallen M, Ekblad E. Effects of total parenteral nutrition on rat enteric nervous system, intestinal morphology, and motility. J Surg Res. 2005;124:187-193.
6. Yang H, Finaly R, Teitelbaum DH. Alteration in epithelial permeability and ion transport in a mouse model of total parenteral nutrition. Crit Care Med. 2003;31:1118-1125.
7. Mok KT, Meng HC. Intestinal, pancreatic and hepatic effects of gastrointestinal hormones in a total parenteral nutrition rat model. JPEN J Parenter Enteral Nutr. 1993;17:364-369.
8. Kansagra K, Stoll B, Rognerud C, et al. Total parenteral nutrition adversely affects gut barrier function in neonatal piglets. Am J Physiol Gastrointest Liver Physiol. 2003;285:G1162-G1170.
9. Der Hulst RR, Von Meyenfeldt MF, Kreel BK, et al. Gut permeability, intestinal morphology, and nutritional depletion. Nutrition. 1998;14:1-6.
10. Perides G, Sharma A, Gopal A, et al. Secretin differentially sensitizes rat pancreatic acini to the effects of supramaximal stimulation with caerulein. Am J Physiol Gastrointest Liver Physiol. 2005;289:G713-G721.
11. Burrin DG, Stoll B. Key nutrients and growth factors for the neonatal gastrointestinal tract. Clin Perinatol. 2002;29:65-96.
12. Gielkens HA, Biggelaar A, Vecht J, Onkenhout W, Lamers CB, Masclee AA. Effect of intravenous amino acids on interdigestive antroduodenal motility and small bowel transit time. Gut. 1999;44:240-245.
13. Nealon WH, Upp JR, Alxander RW. Intravenous amino acids stimulate human gallbladder emptying and hormone release. Am J Physiol. 1990;259:G173-G178.
14. Teitelbaum DH, Han-Markey T, Schummacher RE. Treatment of parenteral nutrition-associated cholestasis with cholecystokinin-octapeptide. J Pediatr Surg. 1995;30:1082-1085.
15. Niebergall-Roth E, Teyssen S, Singer MV. Neurohormonal control of gallbladder motility. Scand J Gastroenterol. 1997;32:737-750.
16. Tsai S, Strouse PJ, Drongowski RA, Islam S, Teitelbaum DH. Failure of cholecystokinin-octapeptide to prevent TPN-associated gallstone disease. J Pediatr Surg. 2005;40:263-267.
17. Teitelbaum DH, Tracy TF, Aouthmany MM, et al. Use of cholecystokinin- octapeptide for the prevention of parenteral nutrition-associated cholestasis. Pediatrics. 2005;115:1332-1340.
18. Kuntz E, Pinget M, Damge P. Cholecystokinin octapeptide: a potential growth factor for pancreatic beta cells in diabetic rats. JOP. 2004;10:464-475.
19. Koop I, Koop H, Gerhardt C, Schafmayer A, Arnold R. Do bile acids exert a negative feedback control of cholecystokinin release? Scand J Gastroenterol. 1989;24:315-320.
20. Walsh JH. Gastrointestinal hormones. In: Johnson LR, ed. Physiology of the Gastrointestinal Tract. New York, NY: Raven Press; 1987:181-253.
21. Joekel CS, Herrington MK, Vanderhool JA, Adrian TE. Postnatal development of circulating cholecystokinin and secretion, pancreatic growth, and exocrine function in guinea pigs. Int J Pancreatol. 1993;13:1-13.
22. Adler G, Beglinger C, Braum U, et al. Interaction of the cholinergic system and cholecystokinin in the regulation of endogenous and exogenous stimulation of pancreatic secretion in humans. Gastroenterology. 1991;100:537-543.
23. Schweiger M, Steffl M, Amselgruber WM. Determination of target cells for cholecystokinin in the porcine pancreas. Ann Anat. 2005;187:209-214.
24. Gasslander T, Smeds S, Blomquvist L, Ihse I. Proliferative response of different exocrine pancreatic cell types to hormonal stimuli. Scand J Gastroenterol. 1990;25:1103-1110.
25. Axelson J, Håkanson R, Ihse I, Lilja I, Fehfeld JF, Sundler F. Effects of endogenous and exogenous cholecystokinin and of infusion with the cholecystokinin antagonist L-364,718 on pancreatic and gastrointestinal growth. Scand J Gastroenterol. 1990;25:471-480.
26. Nylander AG, Chen D, Ihse I, Rehfeld JF, Hakanson R. Pancreatic atrophy in rats produced by the cholecystokinin-A receptor antagonist devazepide. Scand J Gastroenterol. 1992;27:743-747.
27. Ahrén B, Karlsson S. Pancreatic endocrine physiology. In: Clark OH, ed. Textbook of Endocrine Surgery. Philadelphia, PA: W.B. Saunders Company; 1997:562-575.
28. Ahrén B, Ar'Rajab A, Böttcher G, Sundler F, Dunning BE. Presence of galanin in human pancreatic nerves and inhibition of insulin secretion from isolated human islets. Cell Tissue Res. 1991;264:263-267.
29. Ahrén B, Gingerich RL, Havel PJ. Effects of cholecystokinin and glucagon-like peptide I on the secretion of pancreatic polypeptide in mice. Regul Pept. 1995;59:297-302.
30. Guimbaud R, Moreau JA, Bouisson M, et al. Intraduodenal free fatty acids rather than triglycerides are responsible for the release of CCK in humans. Pancreas. 1997;14:76-82.
31. Liddle RA, Goldfine ID, Rosen MS, Taplitz RA, Williams JA. Cholecystokinin bioactivity in human plasma: molecular forms, responses to feeding, and relationship to gallbladder contraction. J Clin Invest. 1985;75:1144-1152.
32. Fölsch UR, Cantor P, Wilms HM, Schafmayer A, Becker HD, Creutzfeldt W. Role of cholecystokinin in the negative feedback control of pancreatic enzyme secretion in conscious rats. Gastroenterology. 1987;92:449-458.
33. Song Y, Lee KY, Chang TM, Chey WY. A secretin releasing peptide exists in dog pancreatic juice. Life Sci. 2000;25:1307-1316.
34. Povoski S, Zhou W, Longnecker DS. Stimulation of in vivo pancreatic growth in the rat is mediated specially by way of cholecystokinin-A receptors. Gastroenterology. 1994;107:1135-1146.
35. Le Drean G, Huerou-Luron I, Gestin M, et al. Pancreatic secretory response to feeding in the calf: CCK-A receptors, but not CCK-B/gastrin receptors are involved. Can J Physiol Pharmacol. 2000;78:813-819.
36. Strader AD, Woods SC. Gastrointestinal hormones and food intake. Gastroenterology. 2005;128:175-191.
37. Mashako MN, Bernard C, Cezard JP. Effect of total parenteral nutrition, constant rate enteral nutrition, and discontinues oral feeding on plasma cholecystokinin immunoreactivity in children. J Pediatr Gastroenterol Nutr. 1987;6:948-952.
38. Axelson J, Fan BG, Ohlsson B, Rehfeld J, Ekelund M, Ihse I. The changes in the rat parotid glands following total parenteral nutrition and pancreatico-biliary diversion are not mediated by cholecystokinin. Int J Pancreatol. 1996;20:109-118.
39. Fan BG, Andrén-Sandberg Å. Influence of an intravenous infusion of amino acids and glucose on the pancreatic exocrine in rats. Chin Med J. 2004;117:1659-1664.
40. Fan BG, Andrén-Sandberg Å. IV hypertonic glucose stimulates the exocrine pancreas in rat. JPEN J Parenter Enteral Nutr. 2006;30:40-44.
41. Sako Y, Grill VE. A 48-hour lipid infusion in the rat time-dependently inhibits glucose-induced insulin secretion and B cell oxidation through a process likely coupled to fatty acid oxidation. Endocrinology. 1990;127:1580-1589.
42. Zhou YP, Grill VE. Long-term exposure of rat pancreatic islets to fatty acids inhibits glucose-induced insulin secretion and biosynthesis through a glucose fatty acids cycle. J Clin Invest. 1994;93:870-876.
43. Iovanna JL, Dusetti NJ, Cadennas MB. Changes in pancreatic trophism and gene expression during a prolonged fasting period in rats. Int J Pancreatol. 1991;8:177-186.
44. Dowling RH, Hosomi M, Stace NH, et al. Hormones and polyamines in intestinal and pancreatic adaptation. Scand J Gastroenterol. 1985;20:84-95.
45. Haarstad H, Petersen H. Short- and long-term effects of secretin and a cholecystokinin-like peptide on pancreatic growth and synthesis of RNA and polyamines. Scan J Gastroenterol. 1989;24:721-732.
46. Miyata T, Enrione EB. The effect of total parenteral nutrition on gastrointestinal hormones in rats. JPEN J Parenter Enteral Nutr. 1993;17:417-421.
47. Fan BG, Salehi A, Sternby B, et al. Total parenteral nutrition influence both endocrine and exocrine function of rat pancreas. Pancreas. 1997;15:147-153.
48. Solomon TE. Physiology of the exocrine pancreas. In: Howard JM, ed. Surgical Diseases of the Pancreas. Philadelphia, PA: Lea & Febiger; 1987:46-65.
49. Chey WY, Chang T. Neural hormonal regulation of exocrine pancreatic secretion. Pancreatology. 2001;1:320-335.
50. Johnson LR. Regulation of gastrointestinal growth. In: Johnson LR, ed. Physiology of the Gastrointestinal Tract. New York, NY: Raven Press; 1981:169-196.
51. Longnecker DS. Hormones and pancreatic cancer. Int J Pancreatol. 1991;9:81-86.
52. Niebergall-Roth E, Singer MV. Enteropancreatic reflexes mediating the pancreatic enzyme response to nutrients. Auton Neurosci. 2006;125:62-69.
53. Gautam D, Han SJ, Heard TS, et al. Cholinergic stimulation of amylase secretion from pancreatic acinar cells studied with muscarinic acetylcholine receptor mutant mice. J Pharmacol Exp Ther. 2005;313:995-1002.
54. Gingras D, Bendayan M. Evaluation of pancreatic amylase mRNA upon cholinergic stimulation of secretion. J Histochem Cytochem. 2005;53:93-103.
55. Qader SS, Salehi A, Hakanson R, Lundquist I, Ekelund M. Long-term infusion of nutrients (total parenteral nutrition) suppresses circulating ghrelin in food-deprived rats. Regul Pept. 2005;131:82-88.
56. Chen D, Anderson K, Iovava JL. Effects of hypercholecystokininemia produced by pancreaticobiliary diversion on pancreatic growth and enzyme mRNA levels in starved rats. Scand J Gastroenterol. 1993;28:311-314.
57. Hara H, Ohyama S, Hira T. Endogenous cholecystokinin plays a role in down-regulation of pancreatic amylase independent of dietary carbohydrate in rats. Regul Pept. 2001;99:103-110.
58. Kim M, Nozu F, Kusama K, Imawari M. Cholecystokinin stimulates the recruitment of the Src-RhoA-phosphoinositide 3-kinase pathway by Vav-2 downstream of G (alpha13) in pancreatic acini. Biochem Biophys Res Commun. 2006;339:271-276.
59. De-Boer SY, Masclee AA, Jebbink MC, Schipper J, Jansen JB, Lamers CB. Effect of intravenous fat on cholecystokinin secretion and gallbladder motility in man. JPEN J Parenter Enteral Nutr. 1992;16:16-19.
60. Grundfest S, Steiger E, Selinkoff P, Fletcher J. The effect of intravenous fat emulsions in patients with pancreatic fistula. JPEN J Parenter Enteral Nutr. 1980;4:27-31.
61. Lee YL, Kwon HY, Park HS. The role of insulin in the interaction of secretin and cholecystokinin in exocrine secretion of the isolated perfused rat pancreas. Pancreas. 1996;1:58-63.
62. Fan BG, Axelson J, Sternby B, Rehfeld J, Ihse I, Ekelund M. Total parenteral nutrition affects the trophic effect of cholecystokinin on the exocrine pancreas. Scand J Gastroenterol. 1997;32:380-386.
63. Shulman RJ, Burrin DG. Total parenteral nutrition energy composition affects small intestinal disaccharides activity in the newborn miniature pig. JPEN J Parenter Enteral Nutr. 1991;15:560-563.
64. Zawalich W, Takuwa N, Takuwa Y. Interactions of cholecystokinin and glucose in rat pancreatic islets. Diabetes. 1987;36:426-433.
65. Samli KN, McGuire MJ, Newgard CB, Johnston SA, Brown KC. Peptide-mediated targeting of the islets of Langerhans. Diabetes. 2005;54:2103-2108.
66. Myojin T, Kitamura N, Hondo E, Baltazar ET, Pearson GT, Yamada J. Immunohistochemical localization of neuropeptides in bovine pancreas. Anat Histol Embryol. 2000;29:167-172.
67. Willianms JA, Goldfine ID. The insulin-acinar relationship. In: Go VLW, ed. The Pancreas: Biology, Pathology and Disease. 2nd ed. New York, NY: Raven Press; 1993:789-800.
68. Krause U, Bertrand L, Maisin L, Rosa M, Hue L. Signaling pathways and combinatory effects of insulin and amino acids in isolated rat hepatocytes. Eur J Biochem. 2002;269:3742-3750.
69. Swanson KC, Benson JA, Matthews JC, Harmon DL. Pancreatic exocrine secretion and plasma concentration of some gastrointestinal hormones in response to abomasal infusion of starch hydrolyzate and/or casein. J Anim Sci. 2004;82:1781-1787.
70. Lenzen S, Schmidt W, Rustenbeck I, Panten U. 2-Ketoglutarate generation in pancreas B-cell mitochondria regulation insulin secretory action of amino acids and 2-keto acids. Biosci Rep. 1986;6:163-169.
71. Li C, Matter A, Kelly A, et al. Effects of a GTP-insensitive mutation of glutamate dehydrogenase on insulin secretion in transgenic mice. J Biol Chem. 2006;281:15064-15072.
72. Zawalich WS, Yamazaki H, Zawalich KC, Cline G. Comparative effects of amino acids and glucose on insulin secretion from isolated rat or mouse islets. J Endocrinol. 2004;183:309-319.
73. Li C, Buettger C, Kwagh J, et al. A signaling role of glutamine in insulin secretion. J Biol Chem. 2004;279:13393-13401.
74. Stratton RJ, Smith TR. Role of enteral and parenteral nutrition in the patient with gastrointestinal and liver disease. Best Pract Res Clin Gastroenterol. 2006;20:441-466.
75. Kraft MD, Btaiche IF, Sacks GS. Review of the refeeding syndromes. Nutr Clin Pract. 2005;20:625-633.
76. Baudouin SV, Evans TW. Nutritional support in critical care. Clin Chest Med. 2003;24:633-644.
77. De Sousa DA, Greene LJ. Intestinal permeability and systemic infections in critically ill patients: effect of glutamine. Crit Care Med. 2005;33:1125-1135.
78. Newsholme P, Procopio J, Lima MM, Pithon-Curi TC, Curi R. Glutamine and glutamate: their central role in cell metabolism and function. Cell Biochem Funct. 2003;21:1-9.
79. Tsuchioka T, Fujiwara T, Sunagawa M. Effects of glutamic acid and taurine on total parenteral nutrition. J Pediatr Surg. 2006;41:1566-1572.
80. Gianotti L, Alexander JW, Gennari R, et al. Oral glutamine decreases bacterial translocation and improves survival in experimental gut-origin sepsis. JPEN J Parenter Enteral Nutr. 1995;19:69-74.
81. Souba WW, Klimberg VS, Plumley DA, et al. The role of glutamine in maintaining a healthy gut and supporting the metabolic response to injury and infection. J Surg Res. 1990;48:383-391.
82. O'Dwyer ST, Smith RJ, Hwang TL, et al. Maintenance of small bowel mucosa with glutamine-enriched parenteral nutrition. JPEN J Parenter Enteral Nutr. 1989;13:579-585.
83. Déchelotte P, Hasselmann M, Cynober L, et al. L-alanyl-L-glutamine dipeptide-supplemented total parenteral nutrition reduces infectious complications and glucose intolerance in critically ill patients: the French Controlled, Randomized, Double-Blind, Multicenter Study. Crit Care Med. 2006;34:598-604.